ASCL1, ACTIVATED BY LMO1 AND MYCN ONCOGENE, IS A MASTER REGULATOR OF DIFFERENTIATION PROGRAM IN ADRENERGIC NEUROBLASTOMA
Ph.D
Saved in:
Main Author: | WANG LU |
---|---|
Other Authors: | MEDICINE |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/164818 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
by: Wang, Lu, et al.
Published: (2021) -
Chromogenic in situ hybridization using routine tissue sections : MYCN in neuroblastoma
by: Thorner, Paul S., et al.
Published: (2010) -
The Potential of Targeting Brain Pathology with Ascl1/Mash1
by: Tang, Bor Luen
Published: (2023) -
Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein
by: Inoue, K.-I., et al.
Published: (2016) -
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL
by: Li, Z, et al.
Published: (2020)